EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

On‐Demand Magnetically‐Activated Drug Delivery from Additively Manufactured Porous Bone Implants to Tackle Antibiotic‐Resistant Infections

Monika Šalandová, Marius Alexander Leeflang, Maria Klimopoulou, Lidy Elena Fratila‐Apachitei, Iulian Apachitei, Amir Abbas Zadpoor

Advanced Materials Technologies · 2024-04 · 9 (8)

DOI: 10.1002/admt.202301616 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials Technologies, online erschienen am 25.02.2024. Verfasst von Monika Šalandová und 5 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Nederlandse Organisatie voor Wetenschappelijk Onderzoek.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study proposes a new concept for an on‐demand drug releasing device intended for integration into additively manufactured (i.e., 3D printed) orthopedic implants. The system comprises a surface with conduits connected to a subsurface reservoir used for storage and on‐demand release of antimicrobial agents, covered with a cap that prevents the antibacterial agents from being released until alternating magnetic field (AMF) raises the temperature of the cap, thus, releasing the stored drug. To demonstrate this concept, Ti6Al4V specimens are directly 3D printed using selective laser melting and their surface, reservoirs, and drug releasing properties are characterized. A new synthetic antimicrobial peptide, SAAP‐148, is thereafter tested for its cytotoxic, osteogenic, and immunomodulatory effects at concentrations relevant for its minimal bactericidal concentration (MBC) and is compared with its natural analogue, LL‐37. The results showed that AMF successfully activated the release from the 3D printed loaded samples. Both peptides demonstrated to be non‐cytotoxic within the MBC levels for macrophages and preosteoblasts and did not influence their osteoimmunomodulatory behavior. The findings of this study indicate that the proposed concept is technically feasible and has the potential to be used for the development of bone implants with on‐demand delivery systems to fight IAI without systemic or continuous local release of antibiotics.

Förderung

  • Nederlandse Organisatie voor Wetenschappelijk Onderzoek

Zitieren

APA

Šalandová, M., Leeflang, M. A., Klimopoulou, M., Fratila‐Apachitei, L. E., Apachitei, I., & Zadpoor, A. A. (2024). On‐Demand Magnetically‐Activated Drug Delivery from Additively Manufactured Porous Bone Implants to Tackle Antibiotic‐Resistant Infections. Advanced Materials Technologies, 9(8). https://doi.org/10.1002/admt.202301616

Vancouver

Šalandová M, Leeflang MA, Klimopoulou M, Fratila‐Apachitei LE, Apachitei I, Zadpoor AA. On‐Demand Magnetically‐Activated Drug Delivery from Additively Manufactured Porous Bone Implants to Tackle Antibiotic‐Resistant Infections. Advanced Materials Technologies. 2024;9(8). doi:10.1002/admt.202301616

BibTeX
@article{alandov2024,
  author = {Šalandová, Monika and Leeflang, Marius Alexander and Klimopoulou, Maria and Fratila‐Apachitei, Lidy Elena and Apachitei, Iulian and Zadpoor, Amir Abbas},
  title = {On‐Demand Magnetically‐Activated Drug Delivery from Additively Manufactured Porous Bone Implants to Tackle Antibiotic‐Resistant Infections},
  journal = {Advanced Materials Technologies},
  year = {2024},
  volume = {9},
  number = {8},
  doi = {10.1002/admt.202301616}
}
Kostenlos starten →